UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User’s Guide for Adult and Pediatric Gastroenterologists

Gastroenterology (New York, N.Y. 1943), 2021-07, Vol.161 (1), p.47-65

2021

Volltextzugriff (PDF)

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Gut, 2021-04, Vol.70 (4), p.725-732

2021

Volltextzugriff (PDF)

A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review

The American journal of gastroenterology, 2019-06, Vol.114 (6), p.874-883

2019

Volltextzugriff (PDF)

Systematic review and meta‐analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease

Alimentary pharmacology & therapeutics, 2020-05, Vol.51 (9), p.831-842

2020

Volltextzugriff (PDF)

Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis

Digestive diseases and sciences, 2023-04, Vol.68 (4), p.1118-1120

2023

Volltextzugriff (PDF)

What Should Gastroenterologists and Patients Know About COVID-19?

Clinical gastroenterology and hepatology, 2020-06, Vol.18 (7), p.1409-1411

2020

Volltextzugriff (PDF)

Ulcerative colitis

The Lancet (British edition), 2017-04, Vol.389 (10080), p.1756-1770

2017

Volltextzugriff (PDF)

COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2022-03, Vol.162 (3), p.987-988

2022

Volltextzugriff (PDF)

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.481-491.e3

2020

Volltextzugriff (PDF)

Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?

Gastroenterology (New York, N.Y. 1943), 2022-04, Vol.162 (5), p.1452-1455

2022

Volltextzugriff (PDF)

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID

Inflammatory bowel diseases, 2022-10, Vol.28 (10), p.1497-1505

2022

Volltextzugriff (PDF)

High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2021-05, Vol.27 (6), p.791-796

2021

Volltextzugriff (PDF)

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Gastroenterology (New York, N.Y. 1943), 2022-01, Vol.162 (1), p.316-319.e5

2022

Volltextzugriff (PDF)

Reappraisal of Coronavirus Disease 2019 Risk for Patients With Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid

Gastroenterology (New York, N.Y. 1943), 2023-01, Vol.164 (1), p.2-4

2023

Volltextzugriff (PDF)

Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2024-06

2024

Volltextzugriff (PDF)

De-escalation of Therapy for Patients With Inflammatory Bowel Disease

Gastroenterology & hepatology, 2022-04, Vol.18 (4), p.213-215

Ungaro, Ryan C

2022

Volltextzugriff (PDF)

Early Ileocecal Resection for Crohn’s Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study

Gastroenterology (New York, N.Y. 1943), 2023-10, Vol.165 (4), p.976-985.e3

2023

Volltextzugriff (PDF)

Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients

Alimentary pharmacology & therapeutics, 2019-11, Vol.50 (10), p.1094-1099

2019

Volltextzugriff (PDF)

Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis: A Reappraisal of the Clinical Trial Data

Clinical gastroenterology and hepatology, 2023-12, Vol.21 (13), p.3433-3436.e1

2023

Volltextzugriff (PDF)

Ultraprocessed Foods and the Risk of Inflammatory Bowel Disease: Is it Time to Modify Diet?

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (2), p.652-654

2022

Volltextzugriff (PDF)

S2701 Economic Costs and Trends in Inflammatory Bowel Disease-Related Hospitalizations and Surgery in the United States

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e1780-e1780

2022

Volltextzugriff (PDF)

S1052 Characterization of Crohn’s Patients That Are Multiple Primary Non-Responders to Biologic Therapies

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e762-e762

2022

Volltextzugriff (PDF)

Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients

Inflammatory bowel diseases, 2020-06, Vol.26 (7), p.1079-1086

2020

Volltextzugriff (PDF)

The Chicago Classification of Pouchitis: An Important Step Toward a Needed Consensus

Clinical gastroenterology and hepatology, 2022-02, Vol.20 (2), p.281-282

2022

Volltextzugriff (PDF)

Early Biologic Treatment Decreases Risk of Surgery in Crohn's Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis

Inflammatory bowel diseases, 2024-07, Vol.30 (7), p.1080-1086

2024

Volltextzugriff (PDF)

1 – 25 von 425

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(420)
Mit Volltextzugriff
(368)

Publikationsform

Sprache

Englisch
(425)

Erscheinungsjahr

n.n

Thema

Science & Technology
(165)
Life Sciences & Biomedicine
(163)
Gastroenterology & Hepatology
(137)
Humans
(120)
Inflammatory Bowel Disease
(90)
Ulcerative Colitis
(52)
Gastroenterology
(46)
Female
(43)
Crohn's Disease
(41)
Male
(41)
Adult
(39)
Patients
(33)
Covid-19
(28)
Middle Aged
(27)
Inflammatory Bowel Diseases
(25)
Inflammatory Bowel Diseases - Drug Therapy
(25)
Crohn’s Disease
(24)
Crohn Disease - Drug Therapy
(22)
Remission
(22)
Retrospective Studies
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User’s Guide for Adult and Pediatric Gastroenterologists

Effect of IBD medications on COVID-19 outcomes: results from an international registry

A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review

Systematic review and meta‐analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease

Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis

What Should Gastroenterologists and Patients Know About COVID-19?

Ulcerative colitis

COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID

High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Reappraisal of Coronavirus Disease 2019 Risk for Patients With Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid

Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease

De-escalation of Therapy for Patients With Inflammatory Bowel Disease

Early Ileocecal Resection for Crohn’s Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study

Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients

Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis: A Reappraisal of the Clinical Trial Data

Ultraprocessed Foods and the Risk of Inflammatory Bowel Disease: Is it Time to Modify Diet?

S2701 Economic Costs and Trends in Inflammatory Bowel Disease-Related Hospitalizations and Surgery in the United States

S1052 Characterization of Crohn’s Patients That Are Multiple Primary Non-Responders to Biologic Therapies

Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients

The Chicago Classification of Pouchitis: An Important Step Toward a Needed Consensus

Early Biologic Treatment Decreases Risk of Surgery in Crohn's Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis

Suchergebnisse filtern